Using Alzheimer’s disease as a case study, this review argues that it might be time to consider a new paradigm in medical research and drug discovery. The existing framework is overly dependent on often unvalidated animal models, particularly transgenic mice. Translational success remains elusive and costly late-stage drug failure is common. The conventional paradigm tends to overlook species differences and assumes that animal-based findings are generally applicable to humans. Could pathways-based research using advanced human-specific models probed with new tools, including those of systems biology, take centre stage? The current transition in chemical toxicology to a 21st-century paradigm could be a model for health research, with probable medical and economic benefits.
Langley, G. R. (2014). Considering a new paradigm for Alzheimer's disease research. Drug discovery today, 19(8), 1114-1124.
Animals Commons, Animal Studies Commons, Comparative and Laboratory Animal Medicine Commons, Laboratory and Basic Science Research Commons, Medicinal and Pharmaceutical Chemistry Commons, Medicinal Chemistry and Pharmaceutics Commons, Pharmaceutics and Drug Design Commons